VOICED : Un cubano de cada cinco recibió al menos una dosis de vacuna nacional

Cuba is advancing its COVID-19 vaccination campaign, with 22% of the population having received a dose of a locally developed vaccine. The country aims to vaccinate its entire population by the end of 2021 using its own vaccines, despite not having emergency use authorization yet. The vaccines, Avdala and Soberana 2, show promising efficacy rates. Cuba plans to apply for emergency use authorization and intends to sell its vaccines internationally.

What percentage of the Cuban population has received a dose of a locally developed COVID-19 vaccine?

• 15%

• 22%

• 30%

• 50%

What is the efficacy rate of the Avdala vaccine?

• 85%

• 62%

• 75%

• 92%

Which protocol allows Cuba to use vaccines in their final development phase?

• Fast Track Approval

• Public Health Intervention

• Emergency Use Authorization

• Clinical Trial Phase 3

What is the expected outcome of combining two doses of Soberana 02 with one dose of Soberana Plus?

• Increased side effects

• Reduced efficacy

• Improved efficacy

• No change in efficacy

What is Cuba's plan regarding its vaccine formula?

• To sell it internationally

• To discontinue its production

• To keep it for domestic use only

• To donate it to neighboring countries